ANVS

ANVS

USD

Annovis Bio Inc. Common Stock

$1.890-0.060 (-3.077%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$1.950

Haut

$2.029

Bas

$1.890

Volume

0.22M

Fondamentaux de l'Entreprise

Capitalisation Boursière

46.2M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.60M

Bourse

NYQ

Devise

USD

Intervalle sur 52 Semaines

Bas $1.11Actuel $1.890Haut $8.93

Actualités Connexes

GlobeNewswire

Annovis Announces $6 Million Registered Direct Offering of Common Stock

MALVERN, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases

Voir plus
Annovis Announces $6 Million Registered Direct Offering of Common Stock
GlobeNewswire

Annovis Announces Novel Biomarker Data in Alzheimer's Patients Supporting Buntanetap's Potential as a Disease-Modifying Treatment

MALVERN, Pa., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases

Voir plus
Annovis Announces Novel Biomarker Data in Alzheimer's Patients Supporting Buntanetap's Potential as a Disease-Modifying Treatment
GlobeNewswire

Annovis Appoints Mark Guerin as Chief Financial Officer

MALVERN, Pa., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc.

Voir plus
Annovis Appoints Mark Guerin as Chief Financial Officer

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.